3/19
08:22 am
plx
Protalix BioTherapeutics (PLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Protalix BioTherapeutics (PLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.